These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 100217
41. Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats. Heuson JC, Legros N, Heimann R. Cancer Res; 1972 Feb; 32(2):233-8. PubMed ID: 5058184 [No Abstract] [Full Text] [Related]
42. Growth factor binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors from rats subject to chronic caloric restriction. Ruggeri BA, Klurfeld DM, Kritchevsky D, Furlanetto RW. Cancer Res; 1989 Aug 01; 49(15):4135-41. PubMed ID: 2501022 [Abstract] [Full Text] [Related]
43. Isolation and purification of rat mammary tumor peroxidase. DeSombre ER, Lyttle CR. Cancer Res; 1978 Nov 01; 38(11 Pt 2):4086-90. PubMed ID: 100215 [Abstract] [Full Text] [Related]
44. Prolactin and growth hormone levels in the anterior pituitary of rats bearing mammary tumor induced by 7,12-dimethylbenz [a] anthracene. Yanai R, Nagasawa H. Gan; 1968 Dec 01; 59(6):543-6. PubMed ID: 5721587 [No Abstract] [Full Text] [Related]
45. Site of origin of mammary tumors induced by 7,12-dimethylbenz(a)anthracene in the rat. Sinha D, Dao TL. J Natl Cancer Inst; 1975 Apr 01; 54(4):1007-9. PubMed ID: 805252 [Abstract] [Full Text] [Related]
50. Prolactin-dependent rat mammary cancer: a model for man? Pearson OH, Llerena O, Llerena L, Molina A, Butler T. Trans Assoc Am Physicians; 1969 Apr 01; 82():225-38. PubMed ID: 5375151 [Abstract] [Full Text] [Related]
52. Hormone, serum, and methylxanthine interactions in the regulation of DNA synthesis in organ-cultured rat mammary tumors. Mayer RM, Diamond EJ, Hollander VP. J Natl Cancer Inst; 1980 Nov 01; 65(5):1033-8. PubMed ID: 6159497 [Abstract] [Full Text] [Related]
53. Hormone dependency of rat mammary carcinoma--a comparison of two assay systems. Sarkar S, Seshadri R, Shah PN, Kothari LS, Ghosh SN. Neoplasma; 1979 Nov 01; 26(4):477-82. PubMed ID: 118387 [Abstract] [Full Text] [Related]
54. Mammary adenocarcinoma induced in organ culture by 7,12-dimethylbenz(a)anthracene. Dao TL, Sinha D. J Natl Cancer Inst; 1972 Aug 01; 49(2):591-3. PubMed ID: 5076832 [No Abstract] [Full Text] [Related]
55. Prolactin binding to R3230AC mammary carcinoma and liver in hormone-treated and diabetic rats. Smith RD, Hilf R, Senior AE. Cancer Res; 1977 Feb 01; 37(2):595-8. PubMed ID: 188551 [Abstract] [Full Text] [Related]
56. Doxorubicin-induced ultrastructural and growth changes in primary cultures of 7,12-dimethylbenz[a]anthracene-induced mammary tumors. Safa AR, Tseng MT. J Natl Cancer Inst; 1983 Mar 01; 70(3):535-40. PubMed ID: 6403744 [Abstract] [Full Text] [Related]
58. A new model system for studying the phosphatidylinositol cycle. Monaco ME, Lippman ME. J Cell Physiol; 1982 Jul 01; 112(1):148-53. PubMed ID: 7050132 [Abstract] [Full Text] [Related]
59. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy. Bodwin JS, Clair T, Cho-Chung YS. Cancer Res; 1978 Oct 01; 38(10):3410-3. PubMed ID: 210938 [Abstract] [Full Text] [Related]
60. Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation. DeSombre ER, Kledzik G, Marshall S, Meites J. Cancer Res; 1976 Feb 01; 36(2 Pt 1):354-8. PubMed ID: 177195 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]